As Teva wins US approval for GSK Advair copy, main fight yet to come
LONDON, Jan 30 (Reuters) - Israel's Teva Pharmaceutical Industries has won U.S. approval to market a copy of GlaxoSmithKline's best-selling Advair inhaler, although the real battle is still to come. [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: Advair, approval, still, battle, although the, inhaler, best-selling, of GlaxoSmithKline's, market, Pharmaceutical Industries, Israel's, (Reuters), LONDON, fight
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/Xrt8lheKFQY/idUSL5N1FK4D8